159 related articles for article (PubMed ID: 11870169)
21. A case of pure red cell aplasia complicated with diffuse large B cell lymphoma, T-cell-rich/histiocyte-rich variant: effectiveness of rituximab and implications for a common immunopathogenic role of B lymphocytes.
Oyaizu N; Kozai Y; Kodo H; Sunaga S; Iwabuchi K; Higashihara M; Mori S
Acta Haematol; 2005; 113(3):194-7. PubMed ID: 15870490
[TBL] [Abstract][Full Text] [Related]
22. T-cell/histiocyte-rich large B-cell lymphoma of stomach.
Barut F; Kandemir NO; Gun BD; Ozdamar SO
J Pak Med Assoc; 2016 Jul; 66(7):905-7. PubMed ID: 27427148
[TBL] [Abstract][Full Text] [Related]
23. Diffuse large B-cell lymphoma and its variants.
Dominis M; Dzebro S; Gasparov S; Pesut A; Kusec R
Croat Med J; 2002 Oct; 43(5):535-40. PubMed ID: 12402391
[TBL] [Abstract][Full Text] [Related]
24. Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base.
Ollila TA; Reagan JL; Olszewski AJ
Leuk Lymphoma; 2019 Dec; 60(14):3426-3433. PubMed ID: 31287335
[TBL] [Abstract][Full Text] [Related]
25. T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness.
Krishnan J; Wallberg K; Frizzera G
Am J Surg Pathol; 1994 May; 18(5):455-65. PubMed ID: 8172320
[TBL] [Abstract][Full Text] [Related]
26. From a pathologist's point of view: Histiocytic cells in Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
Hartmann S
Pathol Res Pract; 2015 Dec; 211(12):901-4. PubMed ID: 26596262
[TBL] [Abstract][Full Text] [Related]
27. Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
Simonitsch-Klupp I; Hauser I; Ott G; Drach J; Ackermann J; Kaufmann J; Weltermann A; Greinix HT; Skrabs C; Dittrich C; Lutz D; Pötter R; Mannhalter C; Lechner K; Chott A; Jaeger U
Leukemia; 2004 Jan; 18(1):146-55. PubMed ID: 14603341
[TBL] [Abstract][Full Text] [Related]
28. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
[TBL] [Abstract][Full Text] [Related]
29. [Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].
Ye ZY; Cao YB; Lin TY; Lin HL
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):654-9. PubMed ID: 18194597
[TBL] [Abstract][Full Text] [Related]
30. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
[TBL] [Abstract][Full Text] [Related]
31. T-cell/histiocyte-rich large B-cell lymphoma.
Pittaluga S; Jaffe ES
Haematologica; 2010 Mar; 95(3):352-6. PubMed ID: 20207840
[No Abstract] [Full Text] [Related]
32.
Schuhmacher B; Bein J; Rausch T; Benes V; Tousseyn T; Vornanen M; Ponzoni M; Thurner L; Gascoyne R; Steidl C; Küppers R; Hansmann ML; Hartmann S
Haematologica; 2019 Feb; 104(2):330-337. PubMed ID: 30213827
[TBL] [Abstract][Full Text] [Related]
33. A clinicopathologic and immunohistochemical study of diffuse large B-cell lymphoma.
Tao K; Zhu X; Xu W; Chen Z; Lu H
Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):112-5. PubMed ID: 12419155
[TBL] [Abstract][Full Text] [Related]
34. T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management.
Abramson JS
Oncologist; 2006 Apr; 11(4):384-92. PubMed ID: 16614234
[TBL] [Abstract][Full Text] [Related]
35. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Stejskalová E; Kabícková E
Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
[TBL] [Abstract][Full Text] [Related]
36. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
Yao XX; Wang JF; Wang YH; Gao N
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
[TBL] [Abstract][Full Text] [Related]
37. Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype.
Hartmann S; Tousseyn T; Döring C; Flüchter P; Hackstein H; Herreman A; Ponzoni M; de Wolf-Peeters C; Facchetti F; Gascoyne RD; Küppers R; Steidl C; Hansmann ML
Int J Cancer; 2013 Dec; 133(11):2609-18. PubMed ID: 23686423
[TBL] [Abstract][Full Text] [Related]
38. Large B-cell lymphomas poor in B cells and rich in PD-1+ T cells can mimic T-cell lymphomas.
Ohgami RS; Zhao S; Natkunam Y
Am J Clin Pathol; 2014 Aug; 142(2):150-6. PubMed ID: 25015854
[TBL] [Abstract][Full Text] [Related]
39. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
Rossi D; Gaidano G
Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
[TBL] [Abstract][Full Text] [Related]
40. T-cell/histiocyte-rich diffuse large B-cell lymphoma. Report of a case diagnosed by fine needle aspiration biopsy with immunohistochemical and molecular pathologic correlation.
Tong TR; Lee KC; Chow TC; Chan OW; Lam WW; Lung R
Acta Cytol; 2002; 46(5):893-8. PubMed ID: 12365226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
